Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Venture Minerals Limited ( (AU:CRI) ).
Critica Limited has appointed engineering group Sedgman to lead a Scoping Study for its flagship Jupiter Rare Earth Project in Western Australia, supported by Snowden Optiro on mining and SRK Consulting on resource updates. The study will integrate a beneficiation-first flowsheet with mining, processing and infrastructure concepts to define a base-case development pathway, establish baseline project economics and set initial capital and operating cost assumptions, marking a key shift from technical validation to structured economic assessment. Parallel technical work, including metallurgical testing with ANSTO, pilot-scale beneficiation with GAVAQ and planning for targeted drilling, is underway to refine flowsheet design, optimise product specifications and de-risk the project ahead of planned pre-feasibility and definitive feasibility studies, positioning Jupiter as a potentially large-scale, capital-efficient rare earths development in a low-risk jurisdiction.
The most recent analyst rating on (AU:CRI) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Venture Minerals Limited stock, see the AU:CRI Stock Forecast page.
More about Venture Minerals Limited
Critica Limited is an ASX-listed minerals company focused on developing the Jupiter Rare Earth Project in Western Australia, a large clay-hosted rare earths deposit. The company is pursuing a mine-to-magnet strategy, emphasising beneficiation-led processing flowsheets and capital-efficient project configurations to supply rare earth products into the global energy transition and advanced manufacturing markets.
YTD Price Performance: -3.85%
Average Trading Volume: 9,951,728
Technical Sentiment Signal: Hold
Current Market Cap: A$72.76M
See more insights into CRI stock on TipRanks’ Stock Analysis page.

